Asthma Med Serevent Linked to Serious Adverse Events, Death

Date Published: Friday, July 18th, 2008 Researchers have just revealed that patients with chronic asthma who take the asthma medication Serevent—also known generically as Salmeterol—on a daily basis are at increased risk for serious adverse events, including death The research involved a 12-week review of 32 clinical trials that involved 62,630 patients. In addition to pointing to serious adverse events with daily Serevent use, the research findings also suggest that the collaborative use of inhaled corticosteroids with Serevent may help reduce such adverse effects. It is important to note that the researchers felt that it remains unclear if the addition of corticosteroids with Serevent eliminates the risk entirely. “We found that the biggest increase in risk was seen in people with asthma who were not taking inhaled... [read full story]